The influnce of Dexmedetomidine used in the surgery of cerebrovascular disease on postoperative cognitive function and its molecular mechanism

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IID-17011576

Enrollment

Unknown

Registered

2017-06-06

Start date

2017-07-01

Completion date

Unknown

Last updated

2017-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebrovascular diseases

Interventions

3:Dexmedetomidine

Eligibility

Sex/Gender

All

Age

18 Years to 67 Years

Inclusion criteria

Inclusion criteria: aged 19-67years, Surface area of 1.7-1.7 m2, ASA I level or II level

Exclusion criteria

Exclusion criteria: patients who can't communicate through the MMSE score

Design outcomes

Primary

Measure	Time frame
human S-100ß;NSE;MMSE score;	—

Countries

China

Contacts

Public ContactLuo Xiaopan

Zhejiang Provincial People's Hospital

lxply@sina.com+86 13588221918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026